Skip to main content
. 2015 Sep 16;6(32):33867–33877. doi: 10.18632/oncotarget.5293

Figure 6. Effect of gefitinib on radiosensitivity.

Figure 6

DKMGvIII−/+ and BS153vIII−/+ cells were treated with gefitinib for 2 h before irradiation. Cell survival of DKMGvIII−/+ and BS153vIII−/+ cells was assesed by colony forming assay A, C. under pre-plating conditions and B. delayed plating conditions (only DKMGvIII+).